Strōma Medical Corporation is a clinical-stage medical device company located in Irvine, California. Strōma has developed the Strōma Laser System (SLS), a patented laser technology to change eye color from brown and hazel to the options of a natural lighter color. This surgically non-invasive treatment is designed to require only a topical anesthetic, be performed in a doctor’s office, require minimal recovery time, and be performed in less than a minute per eye per treatment.
The SLS is a stand-alone technology intended to be leased to refractive surgeons worldwide (e.g., LASIK-certified ophthalmologists). Ophthalmologists with established laser practices generally have the infrastructure necessary to market, recruit, educate, and follow-up with patients.
Strōma is well positioned to capitalize on the large unmet demand for permanant eye-color change. Strōma has commissioned a primary market research study through a US research firm. The study concluded that 17.5% of consumers with dark eyes would undergo the procedure if it were safe and effective, and an additional 35% would consider the procedure under the same conditions in the future. Combined with demographic research findings, Strōma predicts a US market of approximately 850,000 individuals per year. An even greater international market opportunity exists due to larger dark-eyed populations, and a high demand for related cosmetic surgeries. Strōma anticipates a sustainable market opportunity of $2.9B worldwide at maturity.
STRŌMA and Ō are registered trademarks of STRŌMA MEDICAL CORPORATION.
STRŌMA® Laser System is an investigational device that is not currently approved for commercial use.
